Interpace Biosciences, Inc. (IDXG) SEC Filings — 2026
1 SEC filing for Interpace Biosciences, Inc. (IDXG) in 2026.
Filings
- Interpace Pivots to Thyroid Diagnostics After Key Test Reimbursement Loss — 10-K · Mar 30, 2026
1 SEC filing for Interpace Biosciences, Inc. (IDXG) in 2026.
View on ReadTheFiling | About | Contact | Privacy | Terms
Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.